Quantcast

Latest Stem cell treatments Stories

2014-06-25 04:20:56

GOSSELIES, Belgium, June 25, 2014 /PRNewswire/ -- Minimally invasive bone forming product ALLOB(R)in Phase I/IIa trial for delayed union fracture Bone Therapeutics, the regenerative therapy company addressing unmet medical needs in the field of bone diseases and orthopaedics, today announces that the first patient has been treated with its novel allogeneic osteoblastic (bone-forming) cell therapy product ALLOB(R) in its phase...

2014-06-19 08:30:26

GERMANTOWN, Md., June 19, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that select data from the NSI-189 Phase Ib trial in patients with major depressive disorder (MDD) will be presented at the International College of Neuropyschopharmacology (CINP) 2014 World Congress, in Vancouver, Canada. A poster entitled, "Effects of NSI-189, a neurogenic compound, on quantitative electroencephalography (qEEG) in patients with major depressive disorder (MDD) during a phase 1b...

2014-06-18 23:10:57

OMICS Group International is pleased to announce the 3rd International Conference and Exhibition on Cell & Gene Therapy to be held during October 27-29, 2014 in Las Vegas, USA. Cell Therapy conference takes the opportunity to explore the cell and magnify the therapeutization potential on the application grounds of genetic knowhow. Henderson, NV (PRWEB) June 18, 2014 Cell Therapy-2014 is a remarkable event which brings together research eminent from the expertise of cell and gene...

2014-06-18 12:18:46

Journal of Clinical Investigation Parkinson's disease, which affects millions worldwide, results from neuron loss. Transplantation of fetal tissue to restore this loss has shown promise, but ethical concerns over acquiring this tissue limit its use. In a June 17 study in the Journal of Clinical Investigation, Vania Broccoli and others at the San Raffaele Scientific Institute converted fibroblasts into neurons and engrafted them into the brains of rodents with parkinsonism. The cells...

Embryonic Stem Cells Offer Promising Treatment For Multiple Sclerosis
2014-06-17 03:34:58

University of Connecticut Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease. The researchers demonstrated that the embryonic stem cell therapy significantly reduced MS disease severity in animal models, and offered better treatment results than stem...

2014-06-12 23:13:45

Nebulized Pure PRP for COPD is currently being offered at Advanced Rejuvenation in Sarasota, Florida. Inhaled PRP's goal is to help in the suppression of inflammation, activate stem cells in the lungs, improve breathing, and to improve the symptoms of many pulmonary complications including COPD, asthma and chronic lung infections. Sarasota, FL (PRWEB) June 12, 2014 Nebulized Pure PRP may offer COPD sufferers a less expensive and an effective alternative to stem cell therapy. When...

Scientists Successfully Transplant And Grow Stem Cells In Pigs
2014-06-05 03:38:48

Nathan Hurst, University of Missouri One of the biggest challenges for medical researchers studying the effectiveness of stem cell therapies is that transplants or grafts of cells are often rejected by the hosts. This rejection can render experiments useless, making research into potentially life-saving treatments a long and difficult process. Now, researchers at the University of Missouri have shown that a new line of genetically modified pigs will host transplanted cells without the...

2014-06-03 23:02:06

On June 3, at the 7th Annual Massachusetts Life Sciences Innovation Day, Dr. James L. Sherley, Director of The Adult Stem Cell Technology Center, LLC presented a new technology developed to identify drug candidates that are toxic to adult stem cells. This first technology of its kind meets a long-standing unmet need of the pharmaceutical industry, with potential to save billions of dollars in drug development costs each year while accelerating the arrival of new effective, and safe, drugs...

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/translational_regenerative_medicine_market_prospects_2012_2022.html Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to...

2014-05-27 16:25:18

NEW YORK, May 27, 2014 /PRNewswire/ -- Brian Mehling, M.D., an American orthopedic trauma surgeon, founder, and chief medical officer of Blue Horizon International (BHI) and Blue Horizon Charitable Foundation (BHCF), visited with orphaned children on a recent business trip to Abuja and Lagos in Nigeria. After touring the facility, meeting with the founder, and her staff, he also made a $1,000 donation to help the orphanage fulfill its vision to provide shelter for abandoned and...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related